Overview

Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients

Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
Phase II study of Kukoamine B Mesilate in Sepsis Patients
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Chasesun Pharmaceutical Co., LTD
Collaborator:
Southwest Hospital, China